NEB: New England Biolabs Stock Plan Suit Settles for $7.15 Million
New England Biolabs Inc. agreed to pay $7.15 million to settle a lawsuit by former workers who say they were wrongly forced to sell their stock in the genomic research company at an unfair price.
Read full article »
NEB is a Massachusetts-based biotechnology company that discovers and develops enzyme reagents for the life sciences industry.
Read more